Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Short courses of omeprazole, typically 2 to 8 weeks, most often cause mild and temporary issues such as headache, nausea, gas, stomach pain, constipation, or diarrhea. Long-term use over months or years is linked to a different set of concerns, including low magnesium, vitamin B12 deficiency, bone fractures, kidney inflammation, C. difficile infection, stomach polyps, and rebound acid reflux after stopping. Your dose, age, kidney health, and other medications all shift that risk picture, and there are several important distinctions explained below that the short answer leaves out. Because heartburn, reflux, and stomach pain can also signal conditions that acid suppression alone will not fix, it helps to look at your full symptom pattern rather than only the pill you are taking.
If you are unsure whether what you feel is a medication side effect or something else, a free, instant, online symptom check can help you organize your symptoms, see possible causes, and decide whether to adjust treatment with a clinician or seek care sooner.
Last reviewed for medical accuracy: 10/22/2026
Omeprazole is a widely prescribed proton pump inhibitor (PPI) used to reduce stomach acid in conditions like gastroesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome. While generally well tolerated, omeprazole can cause side effects. Understanding how these differ between a short course (up to 14–28 days) and long-term use (months to years) helps you weigh benefits against risks.
Omeprazole blocks the “proton pumps” in stomach lining cells that produce acid. By doing so, it:
Because it acts at the final step of acid production, omeprazole is more potent and longer-lasting than older acid blockers (H2-receptor antagonists).
When used for 2–4 weeks, omeprazole side effects tend to be mild and transient. In large clinical trials, about 5–10% of patients report:
These effects often resolve on their own. If they persist beyond a week or interfere with daily activities, speak to your doctor or pharmacist about adjusting dose or switching medications.
With continuous use beyond three months, certain risks become more prominent. The overall chance of serious complications remains low, but prolonged acid suppression can lead to:
| Side Effect Category | Short Course (≤ 4 weeks) | Long-Term Use (> 3 months) |
|---|---|---|
| Headache | Common, mild | Less common |
| GI Upset | Common (nausea, gas, diarrhea) | May persist or evolve into chronic changes |
| Nutrient Deficiencies | Rare | Increased risk of B12, Mg, Ca deficits |
| Bone Fracture Risk | Negligible | Slightly increased |
| Kidney Injury | Very rare | Small but measurable risk |
| C. diff & Pneumonia | Low risk | Higher risk with prolonged use |
| Rebound Acid Hypersecretion | Unlikely | Possible after discontinuation |
If your condition requires ongoing acid suppression, these strategies can help:
Though most side effects are mild, certain symptoms warrant prompt medical attention:
If you experience any of these, speak to a doctor immediately. For non-urgent concerns, you might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.
Your doctor will weigh your symptoms’ severity, underlying conditions and personal risk factors to decide whether omeprazole is the best option and for how long.
For life-threatening or serious health concerns, speak to a doctor without delay. If you’re unsure about your symptoms, consider the free, online symptom check, using the doctor approved Ubie Symptom Checker.
(References)
* Langman MJ. Omeprazole. Aliment Pharmacol Ther. 1991 Aug;5(4):357-64. doi: 10.1111/j.1365-2036.1991.tb00039.x. PMID: 1777546.
* Howden CW. Clinical pharmacology of omeprazole. Clin Pharmacokinet. 1991 Jan;20(1):38-49. doi: 10.2165/00003088-199120010-00003. PMID: 2029801.
* Viana de Miguel C, Alvarez García M, Sánchez Sánchez A, Carvajal García-Pando A. [Lansoprazole-induced hepatitis]. Med Clin (Barc). 1997 Apr 19;108(15):599. PMID: 9280798.
* Pantoprazole (Protonix). Med Lett Drugs Ther. 2000 Jul 24;42(1083):65-6. PMID: 10908422.
* El-Matary W, Dalzell M. Omeprazole-induced hepatitis. Pediatr Emerg Care. 2005 Aug;21(8):529-30. doi: 10.1097/01.pec.0000173350.45648.9b. PMID: 16096600.
* Darabi K. Proton-pump-inhibitor-induced hepatitis. South Med J. 2005 Aug;98(8):844-5. doi: 10.1097/01.smj.0000172795.75166.c1. PMID: 16144190.
* Pan Y, Chong AH, Williams RA, Green J, Sinclair R. Omeprazole-induced dermatomyositis. Br J Dermatol. 2006 Mar;154(3):557-8. doi: 10.1111/j.1365-2133.2005.07076.x. PMID: 16445794.
* Brauer J, Votava HJ, Meehan S, Soter NA. Lichenoid drug eruption. Dermatol Online J. 2009 Aug 15;15(8):13. Epub 2009 Aug 15. PMID: 19891921.
* Glick A, Sista V, Johnson C. Oral Manifestations of Commonly Prescribed Drugs. Am Fam Physician. 2020 Nov 15;102(10):613-621. PMID: 33179891.
* Lee KN, Lee OY, Chun HJ, Kim JI, Kim SK, Lee SW, Park KS, Lee KL, Choi SC, Jang JY, Kim GH, Sung IK, Park MI, Kwon JG, Kim N, Kim JJ, Lee ST, Kim HS, Kim KB, Lee YC, Choi MG, Lee JS, Jung HY, Lee KJ, Kim JH, Chung H. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J Gastroenterol. 2022 Nov 28;28(44):6294-6309. doi: 10.3748/wjg.v28.i44.6294. PMID: 36504556; PMCID: PMC9730436.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.